Trial intelligence / Profile preview

Zofran vs Ensure for MAC Treatment Tolerance

NCT01719042Phase 2Withdrawn

Sponsor
University of Florida
Start
Jan 2013
Primary completion
Mar 2013
Modality
Small Molecules
01

Overview

A Phase 2 trial of ondansetron in nausea ((none)), Vomiting, sponsored by University of Florida. Planned start Jan 2013; status: withdrawn.

02

Drugs

ondansetron
03

Conditions

nausea ((none))Vomiting

Beyond the preview

Go deeper on NCT01719042.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01719042.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call